Hydrogen Therapy Shows Promise for Lung Disease Prevention and Treatment
- Authors
- Zhilong Liu, Pei Zhao, Yufeng Kang, Wenjun Yan
- Journal
- Zhonghua Wei Zhong Bing Ji Jiu Yi Xue
- Year
- 2026
- DOI
- 10.3760/cma.j.cn121430-20250611-00330
- Study Type
- clinical
- Peer Reviewed
- Yes
- Country
- China
- Health Condition
- Oxidative Stress-Related Pulmonary Diseases
- Body System
- Respiratory
TL;DR
Scientists found that hydrogen gas might be a better way to treat lung diseases caused by damage from harmful molecules called free radicals, because it can get to problem areas in your lungs and fix the damage without the side effects of older treatments. This matters because it could lead to new medicines that help people with serious lung problems breathe better and feel healthier.
Key Finding
Hydrogen shows potential as a selective antioxidant for lung diseases because it can cross biological barriers to reach target tissues and eliminate harmful reactive oxygen species while also reducing inflammation and cell death.
Summary
This review article examines research on how hydrogen gas may help treat lung diseases caused by oxidative stress (damage from harmful molecules called reactive oxygen species). Unlike traditional antioxidants, hydrogen can penetrate deep into tissues and selectively neutralize these harmful molecules while also reducing inflammation and cell death. The authors summarize existing studies to outline how hydrogen might be used to prevent and treat various lung conditions.
Practical Takeaway
This is a review article summarizing existing research rather than a new study with results, so it cannot provide direct evidence about hydrogen's effectiveness in humans. While the review identifies theoretical mechanisms that suggest hydrogen may help with lung diseases, actual clinical evidence in people is still limited. Anyone considering hydrogen therapy for lung conditions should consult their healthcare provider, as more rigorous human studies are needed.
Abstract
Oxidative stress, inflammatory response, and cell apoptosis play important roles in the occurrence, development, and outcome of many diseases, including some lung diseases. During ischemia, hypoxia, or inflammation, the body produces excessive reactive oxygen species (ROS), which non-selectively react with nucleic acids, lipids, and proteins, leading to cellular oxidative damage. Traditional antioxidants exhibit limitations due to their non-specific actions and safety concerns, whereas hydrogen (H2), as a novel selective antioxidant, can readily cross the blood-brain barrier and blood-tissue barriers to rapidly reach target tissues, effectively eliminating ROS. Beyond its antioxidant properties, H2 possesses anti-inflammatory, anti-apoptotic, and autophagy-regulating effects. This review summarizes recent research findings on the therapeutic application of H2 in oxidative stress-related pulmonary diseases, aiming to provide theoretical foundations and research directions for the clinical application of H2 in the prevention and treatment of lung diseases.